5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium

C66H98BBrClN20O4Y+ — CID 158391513

IUPAC5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium
SMILESC=C(CC(C)CC)c1ccc(Br)cn1.CC(C)(C)B1OC(C)(C)C(C)(C)O1.CCC(C)CC(=O)N(C)OC.CCC(C)Cc1nnn2c[c-]cc[n+]12.CC[C@H](C)Cc1nnn2cc(-c3ccnc(Nc4ccnn4C)n3)cc[n+]12.Cn1nccc1Nc1nccc(Cl)n1.[Y]
InChIInChI=1S/C18H22N9.C12H16BrN.C10H21BO2.C10H14N4.C8H8ClN5.C8H17NO2.Y/c1-4-13(2)11-17-23-24-27-12-14(7-10-26(17)27)15-5-8-19-18(21-15)22-16-6-9-20-25(16)3;1-4-9(2)7-10(3)12-6-5-11(13)8-14-12;1-8(2,3)11-12-9(4,5)10(6,7)13-11;1-3-9(2)8-10-11-12-14-7-5-4-6-13(10)14;1-14-7(3-5-11-14)13-8-10-4-2-6(9)12-8;1-5-7(2)6-8(10)9(3)11-4;/h5-10,12-13H,4,11H2,1-3H3,(H,19,21,22);5-6,8-9H,3-4,7H2,1-2H3;1-7H3;4,6-7,9H,3,8H2,1-2H3;2-5H,1H3,(H,10,12,13);7H,5-6H2,1-4H3;/q+1;;;;;;/t13-;;;;;;/m0....../s1
InChIKeyCIPHFZZREOGSIO-DTSSWESASA-N
MW1450.72 g/mol
LogP12.76
Rot. Bonds19

About 5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium

5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium (PubChem CID 158391513) has the molecular formula C66H98BBrClN20O4Y+ and a molecular weight of 1450.72 g/mol. Its IUPAC name is 5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium.

Molecular Properties

Compound Name5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium
PubChem CID158391513
Molecular FormulaC66H98BBrClN20O4Y+
Molecular Weight1450.72 g/mol
Exact Mass1448.61
IUPAC Name5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium
SMILESC=C(CC(C)CC)c1ccc(Br)cn1.CC(C)(C)B1OC(C)(C)C(C)(C)O1.CCC(C)CC(=O)N(C)OC.CCC(C)Cc1nnn2c[c-]cc[n+]12.CC[C@H](C)Cc1nnn2cc(-c3ccnc(Nc4ccnn4C)n3)cc[n+]12.Cn1nccc1Nc1nccc(Cl)n1.[Y]
InChIInChI=1S/C18H22N9.C12H16BrN.C10H21BO2.C10H14N4.C8H8ClN5.C8H17NO2.Y/c1-4-13(2)11-17-23-24-27-12-14(7-10-26(17)27)15-5-8-19-18(21-15)22-16-6-9-20-25(16)3;1-4-9(2)7-10(3)12-6-5-11(13)8-14-12;1-8(2,3)11-12-9(4,5)10(6,7)13-11;1-3-9(2)8-10-11-12-14-7-5-4-6-13(10)14;1-14-7(3-5-11-14)13-8-10-4-2-6(9)12-8;1-5-7(2)6-8(10)9(3)11-4;/h5-10,12-13H,4,11H2,1-3H3,(H,19,21,22);5-6,8-9H,3-4,7H2,1-2H3;1-7H3;4,6-7,9H,3,8H2,1-2H3;2-5H,1H3,(H,10,12,13);7H,5-6H2,1-4H3;/q+1;;;;;;/t13-;;;;;;/m0....../s1
InChIKeyCIPHFZZREOGSIO-DTSSWESASA-N
XLogP12.76
TPSA240.73 Ų
H-Bond Donors2
H-Bond Acceptors21
Rotatable Bonds19
Heavy Atoms94
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001450.72
LogP ≤ 512.76
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze 5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium?
The IUPAC name of 5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium (CID 158391513) is 5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium.
What is the SMILES notation for 5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium?
The canonical SMILES for 5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium is C=C(CC(C)CC)c1ccc(Br)cn1.CC(C)(C)B1OC(C)(C)C(C)(C)O1.CCC(C)CC(=O)N(C)OC.CCC(C)Cc1nnn2c[c-]cc[n+]12.CC[C@H](C)Cc1nnn2cc(-c3ccnc(Nc4ccnn4C)n3)cc[n+]12.Cn1nccc1Nc1nccc(Cl)n1.[Y].
What is the InChIKey of 5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium?
The InChIKey is CIPHFZZREOGSIO-DTSSWESASA-N. The full InChI is InChI=1S/C18H22N9.C12H16BrN.C10H21BO2.C10H14N4.C8H8ClN5.C8H17NO2.Y/c1-4-13(2)11-17-23-24-27-12-14(7-10-26(17)27)15-5-8-19-18(21-15)22-16-6-9-20-25(16)3;1-4-9(2)7-10(3)12-6-5-11(13)8-14-12;1-8(2,3)11-12-9(4,5)10(6,7)13-11;1-3-9(2)8-10-11-12-14-7-5-4-6-13(10)14;1-14-7(3-5-11-14)13-8-10-4-2-6(9)12-8;1-5-7(2)6-8(10)9(3)11-4;/h5-10,12-13H,4,11H2,1-3H3,(H,19,21,22);5-6,8-9H,3-4,7H2,1-2H3;1-7H3;4,6-7,9H,3,8H2,1-2H3;2-5H,1H3,(H,10,12,13);7H,5-6H2,1-4H3;/q+1;;;;;;/t13-;;;;;;/m0....../s1.
What are the key properties of 5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium?
5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium has a molecular weight of 1450.72 g/mol, XLogP of 12.76, 19 rotatable bonds, 2 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-2-(4-methylhex-1-en-2-yl)pyridine;2-tert-butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;4-chloro-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;N-methoxy-N,3-dimethylpentanamide;3-(2-methylbutyl)-7H-tetrazolo[1,2-a]pyridazin-4-ium-7-ide;4-[3-[(2S)-2-methylbutyl]tetrazolo[1,2-a]pyridazin-4-ium-7-yl]-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;yttrium is sourced from PubChem (CID 158391513), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).